CSRC sets forth disclosure requirements for listed pharma companies.
August 19, 2022
CSRC sets forth disclosure requirements for listed pharma companies.
Shanghai revises rules allowing for public interest litigation for consumer rights.
The use of artificial intelligence to generate prescriptions is strictly prohibited
SAMR defines the relevant product market for antitrust involving IP
The level of cybersecurity protection requires assessment.
SAMR proposes to raise the thresholds for concentration filings
Overseas transfer of data includes access to data within China by overseas entities
SAMR specifies exceptions of monopoly agreements
SMAR prohibits platform operators from abusing their dominant market positions
CAC specifies the criteria for transferring personal information out of mainland China with standard contracts